Program

Preuzmi program

Petak - 21.03.2025.

15:30 - 17:30

Registracija sudionika
Hotel - Konferencijsko područje

17:30 - 18:00

SVEČANO OTVARANJE
Glavna konferencijska dvorana

18:00 - 19:30

Plenarna Predavanja
Glavna konferencijska dvorana
Moderator: Ruža Ištuk

18:00 - 18:20

Jesmo li doista učinili iskorak u uspješnosti i poboljšanju kvalitete života u eri precizne onkologije
Izv.prof. dr. sc. Dragan Trivanović, dr. med. / OB Pula, Pula

18:20 - 18:40

Klinička heterogenost – ključni alat za suočavanje s budućim izazovima u zdravstvu
Prim.dr.sc. Nenad Miljković mag.pharm. / European Association of Hospital Pharmacists (EAHP)

18:40 - 19:00

Mikrobiota i lijekovi u hematologiji: dvosmjerna interakcija
Izv.prof. dr. sc. Zinaida Perić, dr. med. / KBC Rijeka, Rijeka

19:00 - 19:20

Onkologija bez granica: Transformacija globalne skrbi oboljelih od raka uz resurse NCODA-e
Michael Reff RPh, MBA, Founder and Executive Director / NCODA, Inc.

19:20 - 19:30

Rasprava

19:30 - 20:00

Satelitski simpozij - JGL
Prolife – Petica za mikrobiotu
Izv.prof.dr.sc. Goran Poropat, dr.med. / KBC Rijeka, Rijeka

20:00 -

ZAJEDNIČKO DRUŽENJE

Subota - 22.03.2025.

09:00 - 10:00

Nove spoznaje u liječenju solidnih tumora
Glavna konferencijska dvorana
Moderator: Eugen Javor, Vlatka Bračić

09:00 - 09:15

Incidencija i prognostička vrijednost ultraniskog PSA u liječenju bolesnika s metastatskim i hormon osjetljivim rakom prostate
dr. sc. Petar Suton, dr. med. / KB Dubrava, Zagreb

09:15 - 09:30

Biomarkerima vođeno liječenje uznapredovaloga raka crijeva
dr. sc. Mirjana Pavlović dr. med. / UPMC Hillman Cancer Center, Zabok

09:30 - 09:45

Mutacije gena BRCA u raku dojke: rezultati KB Dubrava
Martina Bašić Koretić, dr.med. / KB Dubrava, Zagreb

09:45 - 10:00

Rasprava

10:00 - 10:45

Prilagodba edukacije za povećanje učinaka: Upravljanje resursima za skrb oboljelih od raka na globalnoj razini
Glavna konferencijska dvorana

10:00 - 10:30

Prilagodba edukacije za povećanje učinaka: Upravljanje resursima za skrb oboljelih od raka na globalnoj razini
Natasha Khrystolubova, RPH, BPharm, BCOP, Director of Clinical Services / AllyGPO, USA
Christine Lariviere, BPharm, Co-owner / Larivière et Massicotte, Pharmaciennes inc., Quebec, Canada

10:30 - 10:45

Rasprava

10:45 - 11:15

Satelitski simpozij - Astellas
Glavna konferencijska dvorana

Ciljana terapija i inovativni pristupi kao temelj liječenja malignih bolesti

AML R/R: povezanost testiranja, liječenja i učinkovitosti
doc. dr. sc. prim. Delfa Radić-Krišto dr. med. / KB Merkur, Zagreb

Rak želuca: Novi biomarkeri i kombinacijske terapije
Izv. prof. dr. sc. Ivana Mikolašević dr. med. / KBC Rijeka, Rijeka

11:15 - 11:45

Satelitski simpozij - AstraZeneca
Glavna konferencijska dvorana

The ABC of ADCs: Protutijelo i citotoksični lijek kao partneri za budućnost onkološke terapije

Prof. dr. sc. Dinko Vitezić, dr. med. / MF Rijeka / KBC Rijeka, Rijeka
Izv.prof. dr. sc. Zinaida Perić, dr. med. / KBC Rijeka, Rijeka
dr. sc. Petar Suton, dr. med. / KB Dubrava, Zagreb

11:45 - 12:00

Stanka za kavu

12:00 - 13:00

Klinička ispitivanja u Hrvatskoj – novosti i perspektiva
Glavna konferencijska dvorana
Moderator: Eugen Javor

Panelisti
Marija Ličina, Voditelj kliničkih operacija / PSI CRO
Prof. dr. sc. Antonio Juretić, dr.med. / KB Dubrava, Zagreb / HALMED
Damir Rubčić, Voditelj kliničkih projekata / Novo Nordisk Hrvatska
Prof. dr. sc. Dinko Vitezić, dr. med. / MF Rijeka / KBC Rijeka, Rijeka
Ivica Belina, prof. edukac. reh. / Koalicija udruga u zdravstvu / HALMED
dr. sc. Marko Lucijanić, dr. med. / KB Dubrava, Zagreb
Petra Bagović Kostelić, Viši motritelj kliničkih ispitivanja / PPD

13:00 - 13:45

Inovacije u imunoterapiji: Uloga bispecifičnih antitijela u hematološkim malignitetima
Glavna konferencijska dvorana

13:00 - 13:30

Inovacije u hematološkim terapijama
Peter Hillmen, MB ChB, PhD / Head of Hematology Engagement at Apellis Pharmaceuticals, UK

13:30 - 13:45

Rasprava

13:45 - 14:45

STANKA ZA RUČAK

14:45 - 15:30

Put prema napretku: Povezivanje perspektive kliničara i industrije u kliničkim ispitivanjima u onkologiji
Glavna konferencijska dvorana

14:45 - 15:15

Put prema napretku: Povezivanje perspektive kliničara i industrije u kliničkim ispitivanjima u onkologiji
Khalid El Bairi, MD / Cancer Biomarkers Working Group, Morocco

15:15 - 15:30

Rasprava

15:30 - 16:30

Farmakoterapija hematoloških bolesti
Glavna konferencijska dvorana
Moderatori: Marko Skelin, Marina Paladin

15:30 - 15:45

Volumen plazme i trombotski rizik u bolesnika s mijeloproliferativnim neoplazmama
dr. sc. Marko Lucijanić, dr. med. / KB Dubrava, Zagreb

15:45 - 16:00

Limfocitoza i rizik krvarenja kod bolesnika s kroničnom limfocitnom leukemijom liječenim inhibitorima Brutonove tirozin kinaze
dr. sc. Ivan Krečak, dr. med. / OB Šibenik, Šibenik

16:00 - 16:15

Specifičnosti terapije blinatumomabom u bolesnika s akutnom limfoblastičnom leukemijom (ALL)
doc. dr. sc. Iva Ivanko, dr. med. / KBC Sestre milosrdnice, Zagreb

16:15 - 16:30

Rasprava

16:30 - 17:00

Satelitski simpozij - Novo Nordisk
Glavna konferencijska dvorana

Više od kilograma – tko je odgovoran za liječenje debljine?

Zašto debljina mora postati prioritet zdravstvene zaštite?
dr. sc. Božo Radić, dr. med. / Poliklinika Amruševa, Zagreb

Više od izdavanja lijekova – uloga ljekarnika u liječenju debljine
Omar Kaoudahhan, mag.pharm. / Ljekarne Vaše Zdravlje

17:00 - 17:15

Stanka za kavu

17:15 - 18:00

Panel Rasprava: Novosti iz EU Zakonodavstva o Farmaceutskim Proizvodima
Glavna konferencijska dvorana
Moderator: Marko Skelin

Panelisti
Ana Soldo, mag.pharm. / HLJK
Matteo Poidomani, Viši savjetnik za pravne poslove / Affordable Medicines Europe
Ivica Belina, prof. edukac. reh. / Koalicija udruga u zdravstvu / HALMED
Prim.dr.sc. Nenad Miljković mag.pharm. / European Association of Hospital Pharmacists (EAHP)
Mihael Furjan, Predsjednik Uprave / Pliva Hrvatska
Goranka Marušić Kontent, dipl. iur, Savjetnik za europske poslove / HALMED
Ivan Bumber, mag.pharm., Voditelj regulative i odnosa s javnošću ASB-HUB za Istočnu Europu / Pfizer

18:00 - 19:00

Hepatologija i Pretilost
Glavna konferencijska dvorana
Moderatori: Ines Potočnjak, Jurica Vrbanec

18:00 - 18:15

Hepatitis C se može izliječiti
Jasminka Brkičić dr.med. / OB Šibenik, Šibenik

18:15 - 18:30

MASLD – terapijske mogućnosti i nove perspektive
Izv.prof.dr.sc. Goran Poropat, dr.med. / KBC Rijeka, Rijeka

18:30 - 18:45

Pregled kliničkih ispitivanja u debljini – trenutni farmakoterapijski arsenal i nadolazeći farmakodinamski smjerovi
Andrej Belančić, dr. med. / KBC Rijeka, Rijeka

18:45 - 19:00

Rasprava

18:00 - 18:45

Budućnost onkologije: Unaprjeđenje precizne medicine na globalnoj razini
Dvorana A
Moderator: Ruža Ištuk

18:00 - 18:30

Budućnost onkologije: Unaprjeđenje precizne medicine na globalnoj razini
dr. sc. Mirko Grubor, mag. pharm., Voditelj dijagnostike i precizne medicine / AstraZeneca

18:30 - 18:45

Rasprava

20:00 -

Zajedničko druženje

Nedjelja - 23.03.2025.

09:00 - 10:00

Priprema Citotoksičnih Lijekova
Dvorana A
Moderatori: Kaja Matic, Daria Lučiċ

9:00 - 9:15

Sigurnosni protokoli za rukovanje citotoksičnim lijekovima
Hrvoje Prlić, mag.pharm. / KB Merkur, Zagreb

9:15 - 9:30

Prednosti i nedostaci zatvorenih sustava u centralnoj pripremi citostatika
Aurora Antolović-Amidžić, mag. pharm. / KBC Osijek, Osijek

9:30 - 9:45

Specifičnosti pripreme lijekova blinatumomaba i tebentafuspa
Lidija Gajski, mag.pharm. / KBC Zagreb, Zagreb

9:45 - 10:00

Rasprava

09:00 - 10:00

EAHP (The European Association of Hospital Pharmacists)
Glavna konferencijska dvorana
Moderatori: Ana Soldo, Iva Bužančić

9:00 - 9:15

Poboljšanje primjene antibiotika: Edukacijska intervencija u hrvatskoj primarnoj zdravstvenoj zaštiti
Darija Kuruc Poje, mag.pharm. / Opća bolnica Dr. Tomislav Bardek Koprivnica, Koprivnica / EAHP

9:15 - 9:30

Procjena rizika u kliničkim ispitivanjima u onkologiji
Piera Polidori PharmD / RPhar Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello: Palermo, Sicilia, Italia / EAHP

9:30 - 9:45

Ambulantne usluge
Despoina Makridaki PharmD, BSc, RPhar, MSc, MBA / “Sismanoglio Amalia Fleming” G.H. of Attica, Greece / EAHP

9:45 - 10:00

Rasprava

10:00 - 10:15

SENTINEL UMA - PROJEKT
Glavna konferencijska dvorana

Sentinel uma - predstavljanje projekta
Petra Sertić, dr.med. / KBC Sestre milosrdnice, Zagreb

10:15 - 10:30

Satelitski simpozij - AD INTERIM
Glavna konferencijska dvorana

Automatizacija i digitalizacija u zdravstvenom sektoru
Radmila Pavličić, mag.oec., CEO / Ad Interim d.o.o. / Libertas međunarodno sveučilište, Zagreb

10:30 - 10:45

SIGURNOST CITOTOKSIČNIH LIJEKOVA: NAJBOLJE PRAKSE U PRIPREMI IZ EU
Glavna konferencijska dvorana

Centralizirana priprema – praktični savjeti i iskustva iz Estonije
Kristjan Kongi, MPharm / Hospital Pharmacy, North Estonian Medical Centre, Tallinn, Estonia

10:45 - 11:00

Rasprava

11:00 - 12:00

Sigurnost citotoksičnih lijekova preko granica: Najbolje prakse u pripremi kemoterapije iz SAD-a i Ujedinjenog Kraljevstva
Glavna konferencijska dvorana

11:00 - 11:15

Sigurnost citotoksičnih lijekova preko granica: Najbolje prakse u pripremi kemoterapije iz SAD-a
Scott Freeswick, PharmD / Memorial Sloan Kettering Cancer Center, NY, USA

11:15 - 11:30

Sigurnost citotoksičnih lijekova preko granica: Najbolje prakse u pripremi kemoterapije iz UK-a
Joseph Thomas David Williams MPharm, FRPharmS, PG Dip GPP, mBOPA, IPresc. / The Christie NHS Foundation Trust, The University of Manchester, The British Oncology Pharmacy Association (BOPA)

11:30 - 11:45

Rasprava

11:45 - 12:00

Zatvaranje kongresa - završna riječ

Download the program

Friday - 21.03.2025.

15:30 - 17:30

Participant Registration
Hotel - Conference Area

17:30 - 18:00

Official Opening – Welcome Speech
Main Conference Hall

18:00 - 19:30

Plenary Lectures
Main Conference Hall
Moderator: Ruža Ištuk

18:00 - 18:20

Have We Truly Made Progress in Efficacy and Improvement in a Quality of Life in the Era of Precision Oncology
Assoc. prof. Dragan Trivanović, MD, PhD / General Hospital Pula, Pula

18:20 - 18:40

Clinical heterogeneity-an essential tool in meeting future healthcare challenges
Prim. Nenad Miljković, MPharm, PhD / European Association of Hospital Pharmacists (EAHP)

18:40 - 19:00

Microbiota and Drugs in Hematology: A Bidirectional Interaction
Assoc. Prof. Zinaida Perić, MD, PhD / Clinical Hospital Centre Rijeka, Rijeka

19:00 - 19:20

Oncology Without Borders: Transforming Global Cancer Care with NCODA Resources
Michael Reff RPh, MBA, Founder and Executive Director / NCODA Inc.

19:20 - 19:30

Discussion

19:30 - 20:00

Satellite Symposium - JGL

Prolife – A Five-Star for the Microbiota
Assoc. Prof. Goran Poropat, MD, PhD / Clinical Hospital Centre Rijeka, Rijeka

20:00 -

Social Gathering

Saturday - 22.03.2025.

09:00 - 10:00

New Insights in Solid Tumor Treatment
Main Conference Hall
Moderators: Eugen Javor, Vlatka Bračić

09:00 - 09:15

Incidence and Prognostic Value of Ultra-Low PSA in the Treatment of Patients with Metastatic and Hormone-Sensitive Prostate Cancer
Petar Suton, MD, PhD / Clinical Hospital Dubrava, Zagreb

09:15 - 09:30

Biomarker-Driven Treatment of Advanced Colorectal Cancer
Mirjana Pavlović, MD, PhD / UPMC Hillman Cancer Center, Zabok

09:30 - 09:45

BRCA Gene Mutations in Breast Cancer: Results from Clinical Hospital Dubrava
Martina Bašić Koretić, MD / Clinical Hospital Dubrava, Zagreb

09:45 - 10:00

Discussion

10:00 - 10:45

Tailoring Education for Impact: Adapting Cancer Care Resources Globally
Main Conference Hall

10:00 - 10:30

Tailoring Education for Impact: Adapting Cancer Care Resources Globally
Natasha Khrystolubova, RPH, BPharm, BCOP, Director of Clinical Services / AllyGPO, USA
Christine Lariviere, BPharm, Co-owner / Larivière et Massicotte, Pharmaciennes inc., Quebec, Canada

10:30 - 10:45

Discussion

10:45 - 11:15

Satellite Symposium - ASTELLAS
Main Conference Hall

Targeted Therapy and Innovative Approaches as the Foundation of Malignant Disease Treatment

AML R/R: The Relationship Between Testing, Treatment, and Efficacy
Asst. Prof. Delfa Radić-Krišto, MD, PhD, Primarius / Clinical Hospital Merkur, Zagreb

Gastric Cancer: New Biomarkers and Combination Therapies
Assoc. Prof. Ivana Mikolašević, MD, PhD / Clinical Hospital Centre Rijeka, Rijeka

11:15 - 11:45

Satellite Symposium - ASTRAZENECA
Main Conference Hall

The ABC of ADCs: Antibody and Cytotoxic Drug as Partners for the Future of Oncology Therapy

Petar Suton, MD, PhD / Clinical Hospital Dubrava, Zagreb
Prof. Dinko Vitezić, MD, PhD / The Faculty of Medicine of the University of Rijeka / Clinical Hospital Centre Rijeka, Rijeka
Assoc. prof. Zinaida Perić, MD, PhD / Clinical Hospital Centre Rijeka, Rijeka

11:45 - 12:00

Coffee Break

12:00 - 13:00

Clinical Trials in Croatia – Updates and Perspectives
Main Conference Hall
Moderator: Eugen Javor

Panelists
Marija Ličina, Clinical Operations Manager / PSI CRO
Prof. Antonio Juretić, MD, PhD / Clinical Hospital Dubrava, Zagreb / Agency for Medicinal Products and Medical Devices (HALMED)
Damir Rubčić, Clinical Project Lead / Novo Nordisk Croatia
Ivica Belina, Prof. educ. rehab. / Agency for Medicinal Products and Medical Devices (HALMED)
Prof. Dinko Vitezić, MD, PhD / The Faculty of Medicine of the University of Rijeka / Clinical Hospital Centre Rijeka, Rijeka
Marko Lucijanić, MD, PhD / Clinical Hospital Dubrava, Zagreb
Petra Bagović Kostelić, Senior Clinical Research Associate / PPD

13:00 - 13:45

Innovations in Immunotherapy: The Role of Bispecific Antibodies in Hematologic Malignancies
Main Conference Hall

13:00 - 13:30

Innovations in Hematologic Therapies
Steven Bloom, BPharm, Chief Business Officer / Vincerx, North Easton, MA, USA
Peter Hillmen, MB ChB, PhD / Head of Hematology Engagement at Apellis Pharmaceuticals, UK

13:30 - 13:45

Discussion

13:45 - 14:45

Lunch Break

14:45 - 15:30

Pathways to Progress: Bridging Clinician and Industry Perspectives in Oncology Clinical Trials
Main Conference Hall

14:45 - 15:15

Pathways to Progress: Bridging Clinician and Industry Perspectives in Oncology Clinical Trials
Khalid El Bairi, MD / Cancer Biomarkers Working Group, Morocco

15:15 - 15:30

Discussion

15:30 - 16:30

Pharmacotherapy of Hematologic Diseases
Main Conference Hall
Moderators: Marko Skelin, Marina Paladin

15:30 - 15:45

Plasma Volume and Thrombotic Risk in Patients with Myeloproliferative Neoplasms
Marko Lucijanić, MD, PhD / Clinical Hospital Dubrava, Zagreb

15:45 - 16:00

Lymphocytosis and Bleeding Risk in Patients with Chronic Lymphocytic Leukemia Treated with Bruton Tyrosine Kinase Inhibitors
Ivan Krečak, MD, PhD / General Hospital Šibenik, Šibenik

16:00 - 16:15

Specificities of Blinatumomab Therapy in Patients with Acute Lymphoblastic Leukemia (ALL)
Asst. Prof. Iva Ivanko, MD, PhD / Sestre milosrdnice University Hospital Center, Zagreb

16:15 - 16:30

Discussion

16:30 - 17:00

Satellite Symposium - NOVO NORDISK
Main Conference Hall

More Than a Kilogram – Who is Responsible for Obesity Treatment?

Why Obesity Must Become a Healthcare Priority?
Božo Radić, MD, PhD / Amruševa Polyclinic, Zagreb

Beyond Dispensing Medications – The Role of Pharmacists in Obesity Treatment
Omar Kaoudahhan, MPharm. / Vaše Zdravlje Pharmacies

17:00 - 17:15

Coffee Break

17:15 - 18:00

Panel Discussion: Updates from EU Pharmaceutical Legislation
Main Conference Hall
Moderator: Marko Skelin

Panelists:
Ana Soldo, MPharm / Croatian Chamber of Pharmacist
Matteo Poidomani, Senior Policy Advisor / Affordable Medicines Europe
Ivica Belina, Prof. educ. rehab. / Health Associations Coalition / Agency for Medicinal Products and Medical Devices (HALMED)
Primarius Nenad Miljković, MPharm, PhD / European Association of Hospital Pharmacists (EAHP)
Mihael Furjan, CEO / Pliva Croatia
Goranka Marušić Kontent, LLB, European Affairs Counsellor / Agency for Medicinal Products and Medical Devices (HALMED)
Ivan Bumber, MPharm, Policy & Public Affairs Lead ASB-HUB, Eastern Europe / Pfizer

18:00 - 19:00

Hepatology and Obesity
Main Conference Hall
Moderators: Ines Potočnjak, Jurica Vrbanec

18:00 - 18:15

Hepatitis C Can Be Cured
Jasminka Brkičić, MD / General Hospital Šibenik, Šibenik

18:15 - 18:30

MASLD – Therapeutic Options and New Perspectives
Assoc. Prof. Goran Poropat, MD, PhD / Clinical Hospital Centre Rijeka, Rijeka

18:30 - 18:45

Overview of Clinical Trials in Obesity – Current Pharmacotherapeutic Arsenal and Emerging Pharmacodynamic Directions
Andrej Belančić, MD / Clinical Hospital Centre Rijeka, Rijeka

18:45 - 19:00

Discussion

18:00 - 18:45

The Future of Oncology: Driving Precision Medicine Across Borders
Hall A

18:00 - 18:30

The Future of Oncology: Driving Precision Medicine Across Borders
Mirko Grubor, MPharm, PhD / Diagnostics and Precision Medicine Lead / AstraZeneca

18:30 - 18:45

Discussion

20:00 -

Social Gathering

Sunday - 23.03.2025.

09:00 - 10:00

Preparation of Cytotoxic Drugs
Hall A
Moderators: Kaja Matic, Daria Lučiċ

9:00 - 9:15

Safety Protocols for Handling Cytotoxic Drugs
Hrvoje Prlić, MPharm / Clinical Hospital Merkur, Zagreb

9:15 - 9:30

Advantages and Disadvantages of Closed Systems in Central Cytostatic Preparation
Aurora Antolović-Amidžić, Mpharm / Clinical Hospital Centre Osijek, Osijek

9:30 - 9:45

Specificities of drug preparation for blinatumomab and tebentafusp
Lidija Gajski, MPharm / Clinical Hospital Centre Zagreb, Zagreb

9:45 - 10:00

Discussion

09:00 - 10:00

EAHP (The European Association of Hospital Pharmacists)
Main Conference Hall
Moderators: Ana Soldo, Iva Bužančić

9:00 - 9:15

Improving antibiotic stewardship: An educational intervention in Croatian primary healthcare
Darija Kuruc Poje, MPharm / General Hospital Dr. Tomislav Bardek Koprivnica, Koprivnica / EAHP

9:15 - 9:30

Risk assessment in clinical trials in oncology
Piera Polidori PharmD, RPhar / Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello: Palermo, Sicilia, Italia / EAHP

9:30 - 9:45

Outpatient services
Despoina Makridaki PharmD, BSc, RPhar, MSc, MBA / “Sismanoglio Amalia Fleming” G.H. of Attica, Greece / EAHP

9:45 - 10:00

Discussion

10:00 - 10:15

SENTINEL OF THE MIND – PROJECT
Main Conference Hall

Sentinel of the mind - Project presentation
Petra Sertić, MD / Sestre milosrdnice University Hospital Center, Zagreb

10:15 - 10:30

Satellite Symposium - AD INTERIM
Main Conference Hall

Automation and Digitalization in the Healthcare Sector
Radmila Pavličić, M.Econ, CEO & Co-founder / Ad Interim d.o.o. / Libertas međunarodno sveučilište, Zagreb

10:30 - 11:00

CYTOTOXIC DRUG SAFETY: BEST PRACTICES FROM EU
Main Conference Hall

Centralised preparation - practical tips and experience from Estonia
Kristjan Kongi, MPharm / Hospital Pharmacy, North Estonian Medical Centre, Tallinn, Estonia

10:45 - 11:00

Discussion

11:00 - 12:00

Cytotoxic Drug Safety Across Borders: Best Practices in Chemotherapy Preparation from the USA and UK
Main Conference Hall

11:00 - 11:15

Cytotoxic Drug Safety Across Borders: Best Practices in Chemotherapy Preparation from the US
Scott Freeswick, PharmD / Memorial Sloan Kettering Cancer Center, NY, US

11:15 - 11:30

Cytotoxic Drug Safety Across Borders: Best Practices in Chemotherapy Preparation from the UK
Joseph Thomas David Williams MPharm, FRPharmS, PG Dip GPP, mBOPA, IPresc. / The Christie NHS Foundation Trust, The University of Manchester, The British Oncology Pharmacy Association (BOPA)

11:30 - 11:45

Discussion

11:45 - 12:00

Congress Closing